Cagrilintide

Price range: $80.00 through $150.00

The Amylin Analog Peptide is a synthetic peptide derivative structurally related to amylin, a hormone integral to glycemic regulation and appetite control. It has been developed as a stabilized analog specifically for research purposes and is primarily studied in laboratory settings for its potential effects on appetite modulation, glucose metabolism, and peptide pharmacology. Preclinical research involving this amylin analog investigates experimental models of obesity, diabetes, and metabolic disease.

Research involving the Amylin Analog Peptide commonly explores

:• Its role in modulating amylin receptor signaling and appetite suppression in cellular and animal models.
• Potential contributions to improved glycemic control and weight reduction in diabetic and obesity research models.
• Experimental effects on gastric emptying and metabolic rate in controlled laboratory systems.
• Its activity in combination studies with other metabolic agents, with a focus on molecular design and receptor specificity.

The Amylin Analog Peptide is provided as a lyophilized powder strictly for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: AM833, Amylin analog peptide
• Purity: ≥98%
• CAS Number: 2086426-94-5
• Molecular Formula: C196H303N55O59S
• Molecular Weight: Approximately 4352.06 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.

This Amylin Peptide is a long-acting amylin analog peptide investigated for its effects on appetite regulation and metabolic processes in preclinical studies.

Additional information

Size

CAGRI 10 MG, CAGRI 5 MG